• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • Hainan MPA Accelerates Registration Approval for Overseas Medical Devices

Hainan MPA Accelerates Registration Approval for Overseas Medical Devices

Tuesday, 12 May 2020 / Published in Medical Device

Hainan MPA Accelerates Registration Approval for Overseas Medical Devices

On 31.03.2020, the Hainan MPA (Medical Products Administration) announced plans to boost the development of the medical and pharmaceutical industry in the Hainan free trade zone, utilizing digitalization, fast-track processing procedures and real-world data application.

This followed a press conference held by the Hainan MPA on 28th March in which the Hainan MPA discussed in detail the NMPA’s approval of Allergan’s glaucoma drainage tube product using real-world data obtained from Hainan’s Pilot Zone (as reported in our previous newsletter).

Goals to facilitate administrative approvals

– Digitalize the medical device registration procedure in 2 years

– Speed up the approval process for unregistered importing medical devices and pharmaceutical products to:

  • complete within 7 working days if certain conditions are met
  • complete within 48 hours for special emergency situations

– Combining QMS inspections and production license check to shorten the application time

– Reduce the time needed for the technical review of medical devices by 10%

– Actively promote the pilot application of clinical real-world data

With upcoming plans to optimize the Hainan free trade zone, it will attract many overseas enterprises to utilize these business opportunities to enter China’s medical and pharmaceutical industry.

By Jacky Li. Contact Cisema to learn more.

Tagged under: Green Channel

What you can read next

china yy standards
China YY Standards 2022 – New NMPA Updates Announced
Cutting Edge Tech Developments in China
2022 sampling inspection plan
Annual QMS self-inspection reports – Draft guidelines issued

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Registration of Pharmaceuticals in Hong Kong
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China toothpaste filing requirements

    China Toothpaste Filing Requirements

    China Toothpaste Filing Requirements were issue...
  • Building Successful China Medtech Market Entry Strategies

    Webinar | Building Successful China Medtech Market Entry Strategies – From the Market Access Perspective

    Building successful China Medtech market entry ...
  • China cosmetic regulatory violation

    China cosmetic regulatory violation cases reported by the NMPA

    China cosmetics regulatory violation cases were...
  • China medical device real world evidence

    China medical device real world evidence increasingly important

    China medical device real-world evidence is inc...
  • china medical device ifu draft guidelines

    China Medical Device IFU Draft Guidelines released by NMPA

    China Medical Device IFU Draft Guidelines have ...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2003-2023 Cisema. All rights reserved.

TOP